Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells

International Journal of Gynecological Cancer

Volumn 16, Issue 1, 2006, Pages 110-120

  Gielen, S C J P ^a   Hanekamp, E E ^a   Hanifi Moghaddam, P ^a   Sijbers, A M ^b   Van Gool, A J ^b   Burger, C W ^a   Blok, L J ^a   Huikeshoven, F J ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NV ORGANON   (Netherlands)

^c Ruwaard Van Putten Hospital   (Netherlands)

Author keywords

Endometrium; Estrogen; Growth; Microarray; Progesterone

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN; PROGESTERONE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DNA MICROARRAY; ENDOMETRIUM CANCER; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE NUMBER; GENETIC TRANSCRIPTION; GROWTH REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; HYPOTHESIS; PRIORITY JOURNAL;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGESTERONE; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 33645355106     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00279.x     Document Type: Article

References (45)

1. Akhmedkhanov A Zeleniuch-Jacquotte A Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci 2001 943 296 315.
2. Hale GE Hughes CL Cline JM. Endometrial cancer: hormonal factors, the perimenopausal "window of risk, " and isoflavones. J Clin Endocrinol Metab 2002 87 3 15.
3. Schottenfeld D. Epidemiology of endometrial neoplasia. J Cell Biochem Suppl 1995 23 151 9.
4. Persson I Adami HO Bergkvist L et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ 1989 298 147 51.
5. Rose PG. Endometrial carcinoma. N Engl J Med 1996 335 640 9.
6. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988 240 889 95.
7. Green S Walter P Kumar V et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986 320 134 9.
8. Kuiper GG Enmark E Pelto-Huikko M Nilsson S Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996 93 5925 30.
9. Taylor AH Al-Azzawi F Brandenberger AW et al. Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 2000 24 145 55.
10. Fujimoto J Sakaguchi H Aoki I Toyoki H Tamaya T. Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology 2002 62 269 77.
11. Utsunomiya H Suzuki T Harada N et al. Analysis of estrogen receptor alpha and beta in endometrial carcinomas: correlation with ER beta and clinicopathologic findings in 45 cases. Int J Gynecol Pathol 2000 19 335 41.
12. Matsuzaki S Fukaya T Suzuki T Murakami T Sasano H Yajima A. Oestrogen receptor alpha and beta mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 1999 5 559 64.
13. Matsuzaki S Uehara S Murakami T Fujiwara J Funato T Okamura K. Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay. Fertil Steril 2000 74 753 9.
14. Horwitz KB Alexander PS. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 1983 113 2195 201.
15. Kastner P Krust A Turcotte B et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990 9 1603 14.
16. Mote PA Balleine RL McGowan EM Clarke CL. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1999 84 2963 71.
17. Arnett-Mansfield RL deFazio A Wain GV et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res 2001 61 4576 82.
18. Satyaswaroop PG Sivarajah A Zaino RJ Mortel R. Hormonal control of growth of human endometrial carcinoma in the nude mouse model. In Bresciane F King RJB Lippman M Raynaud JP eds. Progress in cancer research and therapy. New York Raven Press 1988 430 5.
19. Blok LJ De Ruiter PE Kuhne EC et al. Progestogenic effects of tibolone on human endometrial cancer cells. J Clin Endocrinol Metab 2003 88 2327 34.
20. Nishida M Kasahara K Oki A Satoh T Arai Y Kubo T. Establishment of eighteen clones of Ishikawa cells. Hum Cell 1996 9 109 16.
21. Auffray C Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 1980 107 303 14.
22. Schena M Shalon D Davis RW Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995 270 467 70.
23. Venables WN Ripley BD. Modern applied statistics with S-PLUS 2nd edn. Berlin: Springer-Verlag;1997.
24. Blok LJ Grossmann ME Perry JE Tindall DJ. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol 1995 9 1610 20.
25. Zava DT Landrum B Horwitz KB McGuire WL. Androgen receptor assay with [3H]methyltrienolone (R1881) in the presence of progesterone receptors. Endocrinology 1979 104 1007 12.
26. Smid M Dorssers LC. GO-Mapper: functional analysis of gene expression data using the expression level as a score to evaluate Gene Ontology terms. Bioinformatics 2004 20 2618 25.
27. Jenssen TK Laegreid A Komorowski J Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001 28 21 8.
28. Becker KG Hosack DA Dennis G Jr. et al. PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 2003 4 61.
29. Van Gorp T Neven P. Endometrial safety of hormone replacement therapy: review of literature. Maturitas 2002 42 93 104.
30. Lentz SS. Advanced and recurrent endometrial carcinoma: hormonal therapy. Semin Oncol 1994 21 100 6.
31. Dardes RC Schafer JM Pearce ST Osipo C Chen B Jordan VC. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells. Gynecol Oncol 2002 85 498 506.
32. Jacobsen BM Richer JK Schittone SA Horwitz KB. New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J Biol Chem 2002 277 27793 800.
33. Pfeiffer D Spranger J Al-Deiri M et al. mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus. Int J Cancer 1997 72 581 6.
34. Horne MC Donaldson KL Goolsby GL et al. Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem 1997 272 12650 61.
35. Berry LD Gould KL. Fission yeast dim1+ encodes a functionally conserved polypeptide essential for mitosis. J Cell Biol. 1997 137 1337 54.
36. Kuo ML Duncavage EJ Mathew R et al. Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res 2003 63 1046 53.
37. Kitani T Okuno S Fujisawa H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett 2003 544 74 8.
38. Schneider C King RM Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988 54 787 93.
39. Russell L Forsdyke DR. A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol 1991 10 581 91.
40. Dai D Wolf DM Litman ES White MJ Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 2002 62 881 6.
41. Milde-Langosch K Bamberger AM Goemann C et al. Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol 2001 127 537 44.
42. Evron E Umbricht CB Korz D et al. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 2001 61 2782 7.
43. Rouault JP Falette N Guehenneux F et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996 14 482 6.
44. Masuya M Katayama N Hoshino N et al. The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors. Int J Hematol 2002 75 269 76.
45. Mutter GL Baak JP Fitzgerald JT et al. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 2001 83 177 85.